In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) was $258.35 for the day, down -6.58% from the previous closing price of $276.55. In other words, the price has decreased by -$6.58 from its previous closing price. On the day, 1.7 million shares were traded.
Ratios:
Our analysis of ALNY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.98 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 23.58 whereas as Long-Term Debt/Eq ratio is at 22.47.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on March 31, 2025, initiated with a Buy rating and assigned the stock a target price of $353.
On March 24, 2025, JP Morgan Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $280 to $328.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 ’25 when Garg Pushkal sold 5,445 shares for $300.00 per share. The transaction valued at 1,633,500 led to the insider holds 20,221 shares of the business.
Garg Pushkal sold 4,321 shares of ALNY for $1,231,485 on Mar 21 ’25. The CMO & EVP Dev & Med Affairs now owns 20,221 shares after completing the transaction at $285.00 per share. On Mar 24 ’25, another insider, PYOTT DAVID E I, who serves as the Director of the company, sold 7,440 shares for $299.00 each. As a result, the insider received 2,224,560 and left with 136 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 14.35 while its Price-to-Book (P/B) ratio in mrq is 291.64.
Stock Price History:
Over the past 52 weeks, ALNY has reached a high of $304.39, while it has fallen to a 52-week low of $144.73. The 50-Day Moving Average of the stock is 2.99%, while the 200-Day Moving Average is calculated to be -0.39%.
Shares Statistics:
A total of 130.31M shares are outstanding, with a floating share count of 124.65M. Insiders hold about 4.40% of the company’s shares, while institutions hold 95.25% stake in the company.
